Segment Data (Tables)

6 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Financial Information for Company's Segments

Financial information for the Company’s segments was as follows:

	Three Months Ended March 31,						Six Months Ended March 31,
(Millions of dollars)	2016			2015			2016			2015
Revenues (A)
Medical	$	2,131		$	1,106		$	4,185		$	2,177
Life Sciences	936			945			1,869			1,925
Total Revenues	$	3,067		$	2,051		$	6,054		$	4,102
Income Before Income Taxes
Medical (B)	$	513		$	328		$	978		$	632
Life Sciences	202			200			404			413
Total Segment Operating Income	715			528			1,381			1,045
Acquisitions and other restructurings	(104		)	(113		)	(225		)	(136		)
Net interest expense	(96		)	(83		)	(187		)	(149		)
Other unallocated items (C)	(139		)	(107		)	(328		)	(250		)
Income Before Income Taxes	$	376		$	225		$	642		$	510

(A) Intersegment revenues are not material.

(B) The amounts for the three and six months ended March 31, 2016 include increases of $116 million and $246 million in the three and six-month periods, respectively, of non-cash amortization expense associated with acquisition-related identifiable intangible assets related to CareFusion.

(C) Primarily comprised of foreign exchange, corporate expenses, and share-based compensation expense.

Revenues by Geographic Areas

Revenues by geographic areas were as follows:

	Three Months Ended March 31,				Six Months Ended March 31,
(Millions of dollars)	2016		2015		2016		2015
Revenues
United States	$	1,719	$	863	$	3,410	$	1,744
International	1,349		1,188		2,644		2,358
Total Revenues	$	3,067	$	2,051	$	6,054	$	4,102